A detailed history of Eliot Finkel Investment Counsel, LLC transactions in Amgen Inc stock. As of the latest transaction made, Eliot Finkel Investment Counsel, LLC holds 26,222 shares of AMGN stock, worth $8.15 Million. This represents 4.82% of its overall portfolio holdings.

Number of Shares
26,222
Previous 26,672 1.69%
Holding current value
$8.15 Million
Previous $7.68 Million 2.95%
% of portfolio
4.82%
Previous 5.16%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

SELL
$268.87 - $324.56 $120,991 - $146,052
-450 Reduced 1.69%
26,222 $7.46 Million
Q4 2023

Jan 18, 2024

SELL
$255.7 - $288.46 $136,799 - $154,326
-535 Reduced 1.97%
26,672 $7.68 Million
Q3 2023

Nov 01, 2023

SELL
$218.65 - $271.46 $160,707 - $199,523
-735 Reduced 2.63%
27,207 $7.31 Million
Q2 2023

Jul 27, 2023

BUY
$214.27 - $253.37 $7,499 - $8,867
35 Added 0.13%
27,942 $6.2 Million
Q1 2023

May 04, 2023

SELL
$225.79 - $275.2 $67,737 - $82,560
-300 Reduced 1.06%
27,907 $6.75 Million
Q4 2022

Jan 30, 2023

SELL
$229.03 - $291.01 $29,773 - $37,831
-130 Reduced 0.46%
28,207 $7.41 Million
Q3 2022

Oct 20, 2022

SELL
$224.46 - $253.15 $17,956 - $20,252
-80 Reduced 0.28%
28,337 $6.39 Million
Q2 2022

Jul 27, 2022

SELL
$230.71 - $256.74 $23,071 - $25,674
-100 Reduced 0.35%
28,417 $6.91 Million
Q1 2022

May 04, 2022

SELL
$219.27 - $242.57 $74,551 - $82,473
-340 Reduced 1.18%
28,517 $6.9 Million
Q4 2021

Jan 27, 2022

SELL
$198.88 - $227.6 $161,092 - $184,356
-810 Reduced 2.73%
28,857 $6.49 Million
Q3 2021

Nov 10, 2021

SELL
$212.27 - $248.7 $4,245 - $4,974
-20 Reduced 0.07%
29,667 $6.31 Million
Q2 2021

Aug 05, 2021

BUY
$233.58 - $259.14 $65,402 - $72,559
280 Added 0.95%
29,687 $7.24 Million
Q1 2021

Aug 05, 2021

BUY
$221.91 - $258.6 $230,120 - $268,168
1,037 Added 3.66%
29,407 $7.32 Million
Q4 2020

Feb 17, 2021

SELL
$216.38 - $257.67 $19,474 - $23,190
-90 Reduced 0.32%
28,370 $6.52 Million
Q3 2020

Nov 16, 2020

SELL
$234.65 - $260.95 $3,519 - $3,914
-15 Reduced 0.05%
28,460 $7.23 Million
Q2 2020

Aug 17, 2020

SELL
$197.81 - $242.74 $126,598 - $155,353
-640 Reduced 2.2%
28,475 $6.72 Million
Q1 2020

May 13, 2020

SELL
$182.24 - $241.7 $72,896 - $96,680
-400 Reduced 1.36%
29,115 $5.9 Million
Q3 2019

Nov 13, 2019

SELL
$174.11 - $208.62 $31,339 - $37,551
-180 Reduced 0.61%
29,515 $5.71 Million
Q2 2019

Aug 02, 2019

SELL
$166.7 - $195.41 $31,672 - $37,127
-190 Reduced 0.64%
29,695 $5.47 Million
Q1 2019

May 15, 2019

SELL
$180.87 - $203.88 $36,174 - $40,776
-200 Reduced 0.66%
29,885 $5.68 Million
Q4 2018

Feb 13, 2019

SELL
$178.4 - $208.25 $8,920 - $10,412
-50 Reduced 0.17%
30,085 $5.86 Million
Q3 2018

Nov 14, 2018

SELL
$185.29 - $208.89 $216,789 - $244,401
-1,170 Reduced 3.74%
30,135 $6.25 Million
Q2 2018

Aug 14, 2018

SELL
$166.05 - $186.51 $4,981 - $5,595
-30 Reduced 0.1%
31,305 $5.78 Million
Q1 2018

May 15, 2018

SELL
$169.43 - $198.0 $121,989 - $142,560
-720 Reduced 2.25%
31,335 $5.34 Million
Q4 2017

Feb 14, 2018

SELL
$168.79 - $188.59 $21,942 - $24,516
-130 Reduced 0.4%
32,055 $5.57 Million
Q3 2017

Nov 08, 2017

BUY
$167.29 - $191.0 $5.38 Million - $6.15 Million
32,185
32,185 $6 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $166B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Eliot Finkel Investment Counsel, LLC Portfolio

Follow Eliot Finkel Investment Counsel, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eliot Finkel Investment Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eliot Finkel Investment Counsel, LLC with notifications on news.